{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:01:33Z","timestamp":1790470893381,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["19K08183"],"award-info":[{"award-number":["19K08183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Radiation doses to the heart are potentially high in patients undergoing radiotherapy for thymoma or thymic carcinoma because of their origin site and propensity for pericardial invasion. We investigated potential relationships between radiation pneumonitis (RP) and the dosimetric parameters of lung and heart substructures in patients with thymic epithelial tumors. This retrospective study included 70 consecutive patients who received definitive or postoperative radiotherapy at a median dose of 58.3\u00a0Gy. Heart substructures were delineated according to a published atlas. The primary end point of\u2009\u2265\u2009grade 2 RP was observed in 13 patients (19%) despite a low lung dose; median lung V20 (i.e. percentage of the volume receiving at least 20\u00a0Gy) was only 16.6%. In a univariate analysis, four lung parameters, heart V35, three pulmonary artery (PA) parameters, two left ventricle parameters, and left atrium V35 were associated with the development of RP. In a multivariate analysis, only PA V35 remained significant (hazard ratio 1.04; 95% CI 1.01\u20131.07, <jats:italic>p<\/jats:italic>\u2009=\u20090.007). PA V35 of the RP versus non-RP groups were 84.2% versus 60.0% (<jats:italic>p<\/jats:italic>\u2009=\u20090.003). The moderate dose sparing of PA could be a candidate as a planning constraint for reducing the risk of RP in thoracic radiotherapy.<\/jats:p>","DOI":"10.1038\/s41598-020-68168-y","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T10:04:08Z","timestamp":1594116248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors"],"prefix":"10.1038","volume":"10","author":[{"given":"Natsuo","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"68168_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley, J. D. et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 16, 187\u2013199. https:\/\/doi.org\/10.1016\/s1470-2045(14)71207-0 (2015).","journal-title":"Lancet Oncol."},{"key":"68168_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","volume":"12","author":"CK Speirs","year":"2017","unstructured":"Speirs, C. K. et al. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer. J. Thorac. Oncol. 12, 293\u2013301. https:\/\/doi.org\/10.1016\/j.jtho.2016.09.134 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"68168_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","volume":"123","author":"B Stam","year":"2017","unstructured":"Stam, B. et al. Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. Radiother. Oncol. 123, 370\u2013375. https:\/\/doi.org\/10.1016\/j.radonc.2017.04.017 (2017).","journal-title":"Radiother. Oncol."},{"key":"68168_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","volume":"125","author":"K Wang","year":"2017","unstructured":"Wang, K. et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non-small-cell lung cancer. Radiother. Oncol. 125, 293\u2013300. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.001 (2017).","journal-title":"Radiother. Oncol."},{"key":"68168_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fonc.2015.00039","volume":"5","author":"NK Taunk","year":"2015","unstructured":"Taunk, N. K., Haffty, B. G., Kostis, J. B. & Goyal, S. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front. Oncol. 5, 39. https:\/\/doi.org\/10.3389\/fonc.2015.00039 (2015).","journal-title":"Front. Oncol."},{"key":"68168_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby, S. C. et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368, 987\u2013998. https:\/\/doi.org\/10.1056\/NEJMoa1209825 (2013).","journal-title":"N. Engl. J. Med."},{"key":"68168_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1470-2045(05)70251-5","volume":"6","author":"SC Darby","year":"2005","unstructured":"Darby, S. C., McGale, P., Taylor, C. W. & Peto, R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 6, 557\u2013565. https:\/\/doi.org\/10.1016\/S1470-2045(05)70251-5 (2005).","journal-title":"Lancet Oncol."},{"key":"68168_CR8","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman, B. M. et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109, 1878\u20131886. https:\/\/doi.org\/10.1182\/blood-2006-07-034405 (2007).","journal-title":"Blood"},{"key":"68168_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA van Nimwegen","year":"2015","unstructured":"van Nimwegen, F. A. et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern. Med. 175, 1007\u20131017. https:\/\/doi.org\/10.1001\/jamainternmed.2015.1180 (2015).","journal-title":"JAMA Intern. Med."},{"key":"68168_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","volume":"34","author":"FA van Nimwegen","year":"2016","unstructured":"van Nimwegen, F. A. et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J. Clin. Oncol. 34, 235\u2013243. https:\/\/doi.org\/10.1200\/JCO.2015.63.4444 (2016).","journal-title":"J. Clin. Oncol."},{"key":"68168_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/0284186X.2010.521192","volume":"50","author":"EX Huang","year":"2011","unstructured":"Huang, E. X. et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol. 50, 51\u201360. https:\/\/doi.org\/10.3109\/0284186X.2010.521192 (2011).","journal-title":"Acta Oncol."},{"key":"68168_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/JTO.0b013e31815e8b73","volume":"3","author":"C Sugie","year":"2008","unstructured":"Sugie, C. et al. Invasive thymoma: postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination. J. Thorac. Oncol. 3, 75\u201381. https:\/\/doi.org\/10.1097\/JTO.0b013e31815e8b73 (2008).","journal-title":"J. Thorac. Oncol."},{"key":"68168_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/s0360-3016(02)03807-5","volume":"55","author":"K Tsujino","year":"2003","unstructured":"Tsujino, K. et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 55, 110\u2013115. https:\/\/doi.org\/10.1016\/s0360-3016(02)03807-5 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68168_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","volume":"85","author":"DA Palma","year":"2013","unstructured":"Palma, D. A. et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 85, 444\u2013450. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.04.043 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68168_CR15","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/cncr.21875","volume":"106","author":"Y Kobayashi","year":"2006","unstructured":"Kobayashi, Y. et al. Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action. Cancer 106, 1901\u20131907. https:\/\/doi.org\/10.1002\/cncr.21875 (2006).","journal-title":"Cancer"},{"key":"68168_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","volume":"79","author":"M Feng","year":"2011","unstructured":"Feng, M. et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 79, 10\u201318. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.10.058 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68168_CR17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ane.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober, P. et al. Correlation coefficients: appropriate use and interpretation. Anesth. Analg. 126, 1763\u20131768. https:\/\/doi.org\/10.1213\/ane.0000000000002864 (2018).","journal-title":"Anesth. Analg."},{"key":"68168_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"68168_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1259\/bjr\/13604628","volume":"85","author":"M Nomura","year":"2012","unstructured":"Nomura, M. et al. Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation. Br. J. Radiol. 85, 813\u2013818. https:\/\/doi.org\/10.1259\/bjr\/13604628 (2012).","journal-title":"Br. J. Radiol."},{"key":"68168_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.radonc.2010.02.006","volume":"95","author":"H Asakura","year":"2010","unstructured":"Asakura, H. et al. Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer. Radiother. Oncol. 95, 240\u2013244. https:\/\/doi.org\/10.1016\/j.radonc.2010.02.006 (2010).","journal-title":"Radiother. Oncol."},{"key":"68168_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3109\/0284186X.2013.831185","volume":"53","author":"SL Tucker","year":"2014","unstructured":"Tucker, S. L. et al. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort. Acta Oncol. 53, 590\u2013596. https:\/\/doi.org\/10.3109\/0284186X.2013.831185 (2014).","journal-title":"Acta Oncol."},{"key":"68168_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3109\/0284186X.2012.747696","volume":"52","author":"J Dang","year":"2013","unstructured":"Dang, J. et al. Predictors of grade >\/= 2 and grade >\/= 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy. Acta Oncol. 52, 1175\u20131180. https:\/\/doi.org\/10.3109\/0284186X.2012.747696 (2013).","journal-title":"Acta Oncol."},{"key":"68168_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ijrobp.2007.05.065","volume":"69","author":"P van Luijk","year":"2007","unstructured":"van Luijk, P. et al. The impact of heart irradiation on dose-volume effects in the rat lung. Int. J. Radiat. Oncol. Biol. Phys. 69, 552\u2013559. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.05.065 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68168_CR24","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1158\/0008-5472.CAN-05-0786","volume":"65","author":"P van Luijk","year":"2005","unstructured":"van Luijk, P. et al. Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res. 65, 6509\u20136511. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0786 (2005).","journal-title":"Cancer Res."},{"key":"68168_CR25","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1158\/0008-5472.CAN-04-3466","volume":"65","author":"A Novakova-Jiresova","year":"2005","unstructured":"Novakova-Jiresova, A., van Luijk, P., van Goor, H., Kampinga, H. H. & Coppes, R. P. Pulmonary radiation injury: identification of risk factors associated with regional hypersensitivity. Cancer Res. 65, 3568\u20133576. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3466 (2005).","journal-title":"Cancer Res."},{"key":"68168_CR26","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/j.ijrobp.2012.07.2362","volume":"84","author":"G Ghobadi","year":"2012","unstructured":"Ghobadi, G. et al. Physiological interaction of heart and lung in thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 84, e639-646. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.07.2362 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68168_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3109\/0284186X.2012.718093","volume":"51","author":"IR Vogelius","year":"2012","unstructured":"Vogelius, I. R. & Bentzen, S. M. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 51, 975\u2013983. https:\/\/doi.org\/10.3109\/0284186X.2012.718093 (2012).","journal-title":"Acta Oncol."},{"key":"68168_CR28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.ijrobp.2004.08.025","volume":"61","author":"M Fay","year":"2005","unstructured":"Fay, M. et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 61, 1355\u20131363. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.08.025 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68168_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","volume":"85","author":"A McWilliam","year":"2017","unstructured":"McWilliam, A. et al. Radiation dose to heart base linked with poorer survival in lung cancer patients. Eur. J. Cancer 85, 106\u2013113. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.053 (2017).","journal-title":"Eur. J. Cancer"},{"key":"68168_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","volume":"35","author":"RT Dess","year":"2017","unstructured":"Dess, R. T. et al. Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer. J. Clin. Oncol. 35, 1395\u20131402. https:\/\/doi.org\/10.1200\/JCO.2016.71.6142 (2017).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68168-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:04:22Z","timestamp":1670331862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68168-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68168"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68168-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11191"}}